Caliper Life Sciences’s LabChip XT is an automated nucleic acid fractionation instrument designed to remove a key bottleneck in the current workflow for next generation sequencing. It replaces the gel isolation and purification steps used for size selection of sheared genomic DNA. The LabChip XT and its integrated software utilize a multi-channel microfluidic chip to quickly process samples independently and without the potential for cross contamination.
“The LabChip XT was developed in collaboration with leading sequencing centers and providers of next generation sequencing instrumentation and chemistries,” said Kevin Hrusovsky, president and CEO, Caliper Life Sciences. “We are collaborating with our newly formed Sequencing Science Advisory Board to demonstrate these sequencing workflow improvements as well as to develop additional technology platforms in this sector.”
Filed Under: Drug Discovery
